Annual Non Current Assets
$161.13 M
+$105.40 M+189.10%
30 June 2024
Summary:
Renovaro Biosciences annual long term assets is currently $161.13 million, with the most recent change of +$105.40 million (+189.10%) on 30 June 2024. During the last 3 years, it has fallen by -$7.57 million (-4.49%). RENB annual non current assets is now -4.75% below its all-time high of $169.16 million, reached on 01 June 2020.RENB Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$119.88 M
-$41.25 M-25.60%
30 September 2024
Summary:
Renovaro Biosciences quarterly long term assets is currently $119.88 million, with the most recent change of -$41.25 million (-25.60%) on 30 September 2024. Over the past year, it has increased by +$64.27 million (+115.56%). RENB quarterly non current assets is now -43.20% below its all-time high of $211.06 million, reached on 31 March 2024.RENB Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +189.1% | +115.6% |
| 3 y3 years | -4.5% | -28.9% |
| 5 y5 years | -3.7% | -29.2% |
RENB Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.5% | +189.1% | -43.2% | +115.6% |
| 5 y | 5 years | -4.8% | +189.1% | -43.2% | +115.6% |
| alltime | all time | -4.8% | -43.2% |
Renovaro Biosciences Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $119.88 M(-25.6%) |
| June 2024 | $2.00 M(-22.1%) | $161.13 M(-23.7%) |
| Mar 2024 | - | $211.06 M(+279.5%) |
| Dec 2023 | - | $55.62 M(-0.1%) |
| Sept 2023 | - | $55.66 M(-0.1%) |
| June 2023 | $2.57 M(-73.2%) | - |
| June 2023 | - | $55.74 M(-25.5%) |
| Mar 2023 | - | $74.80 M(-0.1%) |
| Dec 2022 | - | $74.88 M(-0.1%) |
| Sept 2022 | - | $74.94 M(-0.2%) |
| June 2022 | $9.57 M(-54.2%) | $75.07 M(-55.4%) |
| Mar 2022 | - | $168.41 M(-0.1%) |
| Dec 2021 | - | $168.52 M(-0.1%) |
| Sept 2021 | - | $168.61 M(-0.1%) |
| June 2021 | $20.90 M(+133.7%) | $168.71 M(-0.0%) |
| Mar 2021 | - | $168.78 M(-0.1%) |
| Dec 2020 | - | $168.88 M(-0.1%) |
| Sept 2020 | - | $169.07 M(-0.1%) |
| June 2020 | $8.94 M(-28.4%) | $169.16 M(-0.0%) |
| Mar 2020 | - | $169.24 M(-0.0%) |
| Dec 2019 | - | $169.30 M(-0.1%) |
| Sept 2019 | - | $169.41 M(+1.2%) |
| June 2019 | $12.49 M(-20.7%) | $167.38 M(+5.4%) |
| Mar 2019 | - | $158.80 M(-1.2%) |
| Dec 2018 | - | $160.69 M(-1.0%) |
| Sept 2018 | - | $162.25 M(-2.7%) |
| June 2018 | $15.76 M | $166.74 M(+31.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $127.20 M(>+9900.0%) |
| Dec 2017 | - | $589.30 K(+7.2%) |
| Sept 2017 | - | $549.90 K(+70.1%) |
| June 2017 | $4.20 M(+473.2%) | $323.30 K(+119.0%) |
| Mar 2017 | - | $147.60 K(-1.2%) |
| Dec 2016 | - | $149.40 K(-6.7%) |
| Sept 2016 | - | $160.10 K(+15.7%) |
| June 2016 | $732.50 K(-61.6%) | $138.40 K(-4.8%) |
| Mar 2016 | - | $145.40 K(+1.7%) |
| Dec 2015 | - | $142.90 K(-12.3%) |
| Sept 2015 | - | $162.90 K(-2.7%) |
| June 2015 | $1.91 M(-62.2%) | - |
| Mar 2015 | - | $167.40 K(-13.5%) |
| Dec 2014 | $5.05 M(>+9900.0%) | $193.60 K(-6.3%) |
| Sept 2014 | - | $206.60 K(-30.1%) |
| June 2014 | - | $295.60 K(-16.0%) |
| Mar 2014 | - | $351.70 K(>+9900.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | $20.00 K(+47.1%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | $13.60 K(>+9900.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00 |
| Mar 2011 | $0.00 | - |
FAQ
- What is Renovaro Biosciences annual long term assets?
- What is the all time high annual non current assets for Renovaro Biosciences?
- What is Renovaro Biosciences annual non current assets year-on-year change?
- What is Renovaro Biosciences quarterly long term assets?
- What is the all time high quarterly non current assets for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly non current assets year-on-year change?
What is Renovaro Biosciences annual long term assets?
The current annual non current assets of RENB is $161.13 M
What is the all time high annual non current assets for Renovaro Biosciences?
Renovaro Biosciences all-time high annual long term assets is $169.16 M
What is Renovaro Biosciences annual non current assets year-on-year change?
Over the past year, RENB annual long term assets has changed by +$105.40 M (+189.10%)
What is Renovaro Biosciences quarterly long term assets?
The current quarterly non current assets of RENB is $119.88 M
What is the all time high quarterly non current assets for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly long term assets is $211.06 M
What is Renovaro Biosciences quarterly non current assets year-on-year change?
Over the past year, RENB quarterly long term assets has changed by +$64.27 M (+115.56%)